mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |